Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
Alzheimers Dement. 2023 Apr;19(4):1234-1244. doi: 10.1002/alz.12763. Epub 2022 Aug 15.
Limbic age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is common in advanced age and can underlie a clinical presentation mimicking Alzheimer's disease (AD). We studied whether an autopsy-derived fluorodeoxyglucose positron emission tomography (FDG-PET) signature of LATE-NC provides clinical utility for differential diagnosis of amnestic dementia patients.
Ante mortem FDG-PET patterns from autopsy-confirmed LATE-NC (N = 7) and AD (N = 23) patients were used to stratify an independent cohort of clinically diagnosed AD dementia patients (N = 242) based on individual FDG-PET profiles.
Autopsy-confirmed LATE-NC and AD groups showed markedly distinct temporo-limbic and temporo-parietal FDG-PET patterns, respectively. Clinically diagnosed AD dementia patients showing a LATE-NC-like FDG-PET pattern (N = 25, 10%) were significantly older, showed less abnormal AD biomarker levels, lower APOE ε4, and higher TMEM106B risk allele load. Clinically, they exhibited a more memory-predominant profile and a generally slower disease course.
An autopsy-derived temporo-limbic FDG-PET signature identifies older amnestic patients whose clinical, genetic, and molecular biomarker features are consistent with underlying LATE-NC.
边缘性与年龄相关的 TDP-43 脑蛋白病病理改变(LATE-NC)在高龄人群中较为常见,可能导致类似阿尔茨海默病(AD)的临床表现。我们研究了 LATE-NC 的尸检衍生氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)特征是否为遗忘型痴呆患者的鉴别诊断提供临床应用价值。
使用经尸检证实的 LATE-NC(N=7)和 AD(N=23)患者的生前 FDG-PET 模式,根据个体 FDG-PET 图谱对独立的临床诊断为 AD 痴呆患者队列(N=242)进行分层。
经尸检证实的 LATE-NC 和 AD 组分别显示出明显不同的颞叶-边缘和颞叶-顶叶 FDG-PET 模式。表现出 LATE-NC 样 FDG-PET 模式的临床诊断为 AD 痴呆患者(N=25,10%)年龄明显更大,表现出更低的异常 AD 生物标志物水平、更低的 APOE ε4 和更高的 TMEM106B 风险等位基因负荷。临床上,他们表现出更以记忆为主的特征和一般更慢的疾病进程。
经尸检衍生的颞叶-边缘 FDG-PET 特征可识别出年龄较大的遗忘型患者,其临床、遗传和分子生物标志物特征与潜在的 LATE-NC 一致。